Credit Agricole
UTHR icon

Credit Agricole’s United Therapeutics UTHR Stock Holding History

Credit Agricole’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.83M Buy
7,066
+358
+5% +$202K 0.01% 785
2026
Q1 		$3.98M Buy
6,708
+4,997
+292% +$2.49M 0.01% 675
2025
Q4 		$834K Sell
1,711
-103
-6% -$48K ﹤0.01% 1083
2025
Q3 		$760K Buy
+1,814
New +$610K ﹤0.01% 977
2025
Q1 		$2.6M Sell
8,466
-187
-2% -$64.1K 0.01% 685
2024
Q4 		$3.05M Buy
8,653
+2,714
+46% +$998K 0.01% 667
2024
Q3 		$2.13M Sell
5,939
-261
-4% -$88.2K 0.01% 605
2024
Q2 		$1.98M Buy
+6,200
New +$1.64M 0.01% 572
2017
Q4 		– Sell
-14,276
Closed -$1.67M – 1060
2017
Q3 		$1.67M Buy
14,276
+1,270
+10% +$162K 0.01% 958
2017
Q2 		$1.69M Sell
13,006
-10,429
-45% -$1.3M 0.01% 988
2017
Q1 		$2.95M Sell
23,435
-2,764
-11% -$419K 0.01% 894
2016
Q4 		$3.76M Sell
26,199
-2,258
-8% -$288K 0.01% 773
2016
Q3 		$3.36M Buy
28,457
+2,551
+10% +$307K 0.01% 796
2016
Q2 		$2.74M Buy
25,906
+5,089
+24% +$568K 0.01% 766
2016
Q1 		$2.32M Sell
20,817
-2,225
-10% -$282K 0.01% 729
2015
Q4 		$3.61M Buy
23,042
+3,597
+18% +$524K 0.02% 651
2015
Q3 		$2.55M Buy
19,445
+3,778
+24% +$606K 0.01% 756
2015
Q2 		$2.73M Sell
15,667
-11,214
-42% -$2.02M 0.01% 772
2015
Q1 		$4.63M Sell
26,881
-17,450
-39% -$2.66M 0.02% 636
2014
Q4 		$5.58M Sell
44,331
-21,031
-32% -$2.71M 0.02% 602
2014
Q3 		$8.41M Buy
65,362
+21,495
+49% +$2.22M 0.04% 466
2014
Q2 		$3.88M Buy
43,867
+19,067
+77% +$1.83M 0.02% 705
2014
Q1 		$2.33M Buy
24,800
+4,500
+22% +$460K 0.01% 838
2013
Q4 		$2.29M Sell
20,300
-700
-3% -$63.1K 0.01% 830
2013
Q3 		$1.66M Buy
+21,000
New +$1.53M 0.01% 907

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Credit Agricole's UTHR Position: Q2 2026 in Review

Credit Agricole increased its United Therapeutics (UTHR) stake by 5.3% in Q2 2026, buying an estimated $202K and bringing the position to 7,066 shares worth $3.83M. The position accounts for 0.01% of the portfolio, ranked #785.

Credit Agricole first reported a position in UTHR in Q3 2013 and has held it in 25 quarters since. The position peaked at $8.41M in Q3 2014. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Credit Agricole held 7,066 shares of United Therapeutics worth $3.83M as of Q2 2026.
  • Credit Agricole bought 358 United Therapeutics shares in Q2 2026, an estimated $202K.
  • United Therapeutics made up 0.01% of Credit Agricole's portfolio in Q2 2026, its #785 holding.
  • Credit Agricole first reported a position in United Therapeutics in Q3 2013 and has held it in 25 quarters since.
  • Credit Agricole's United Therapeutics position peaked at $8.41M in Q3 2014.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.